Cytoprotection by nipradilol, an anti-glaucomatous agent, via down-regulation of apoptosis related gene expression and activation of NF-κB

Experimental Eye Research

Volumn 80, Issue 4, 2005, Pages 501-507

  Ando, Akira ^a   Yamazaki, Yukari ^a   Kaneko, Shiho ^a   Miyake, Maki ^a   Nambu, Rie ^a   Taomoto, Makoto ^a   Unezaki, Sawako ^a   Okuda Ashitaka, Emiko ^a   Okumura, Tadayoshi ^a   Ito, Seiji ^a   Matsumura, Miyo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bax; Caspase 9; Gene expression; Nipradilol; Nitric oxide; No; Nuclear factor B (NF B); PC12 cell; smac DIABLO; and 1 receptor antagonist

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CASPASE 2; CASPASE 3; CASPASE 9; DENITRONIPRADILOL; FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; NIPRADILOL; NITRIC OXIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DNA PROBE; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLAUCOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION;

EID: 20144370551     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2004.10.014     Document Type: Article

References (39)

1. T. Adachi, S. hrori, K. Miyazaki, E. Takahashi, M. Nakagawa, A. Udagawa, N. hrayashi, N. Aikawa, and S. Ogawa Rapid increase in plasma nitrite concentration following intravenous administration of nipradilol Eur. J. Pharmacol. 286 1995 201 204
2. B. Antonsson, F. Conti, A. Ciavatta, S. Montessuit, S. Lewis, I. Martinou, L. Bernasconi, A. Bernard, J.J. Mermod, G. Mazzei, K. Maundress, F. Gambale, R. Sadoul, and J.C. Martinou Inhibition of Bax channel-forming activity by BCL-2 Science 277 1997 370 372
3. M. Bentires-Alj, E. Dejardin, P. Viatour, C. Van Lint, B. Froesch, J.C. Reed, M.P. Merville, and V. Bours Inhibition of the NF-κB transcription factor increases Bax expression in cancer cell lines Oncogene 20 2001 2805 2813
4. G. Chidlow, K.G. Schmidt, J.P.M. Wood, J. Melena, and N.N. Osborne α-Lipoic acid protects the retina against ischemia-reperfusion Neuropharmacology 43 2002 1015 1025
5. C. Du, M. Fang, Y. Li, L. Li, and X. Wang Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 102 2000 33 42
6. A.G. Estevez, N. Spear, J.A. Thompson, T.L. Cornwell, R. Radi, L. Barbeito, and J.S. Beckman Nitric oxide-dependent production of cGMP supports the survival of rat embryonic motor neurons cultured with brain-derived neurotrophic factor J. Neurosci. 18 1998 3708 3714
7. S.E. Farinelli, D.S. Park, and L.A. Greene Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism J. Neurosci. 16 1996 2325 2334
8. A.M. Genaro, S. hrortelano, A. Alvarez, C. Martinez, and L. Bosca Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels J. Clin. Invest. 95 1995 1884 1890
9. I.M. Goldstein, P. Ostwald, and S. Roth Nitric oxide: a review of its role in retinal function and disease Vision Res. 36 1996 2979 2994
10. M. Kanno, M. Araie, K. Tomita, and K. Sawanobori Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation Invest. Ophthalmol. Vis. Sci. 39 1998 736 743
11. M. Kanno, M. Araie, H. Koibuchi, and K. Masuda Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humans Br. J. Ophthalmol. 84 2000 293 299
12. S. Kashii, M. Mandai, M. Kikuchi, Y. hronda, Y. Tamura, K. Kaneda, and A. Akaike Dual actions of nitric oxide in N-methyl-d-aspartate receptor-mediated neurotoxicity in cultured retinal neurons Brain Res. 711 1996 93 101
13. K. Kashiwagi, Y. Iizuka, and S. Tsukahara Neuroprotective effects of nipradilol on purified cultured retinal ganglion cells J. Glaucoma 11 2002 231 238
14. L.A. Kerrigan, D.J. Zack, H.A. Quigley, S.D. Smith, and M.E. Pease TUNEL-positive ganglion cells in human primary open-angle glaucoma Arch. Ophthalmol. 115 1997 1031 1035
15. Y.M. Kim, R.V. Talanian, and T.R. Billiar Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms J. Biol. Chem. 272 1997 31138 31148
16. Y.M. Kim, T.H. Kim, D.W. Seol, R.V. Talanian, and T.R. Billiar Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release J. Biol. Chem. 273 1998 31437 31441
17. Y.M. Kim, C.A. Bombeck, and T.R. Billiar Nitric oxide as a bifunctional regulator of apoptosis Circ. Res. 84 1999 253 256
18. Y.M. Kim, H.T. Chung, S.S. Kim, J.A. hran, Y.M. Yoo, K.M. Kim, G.H. Lee, H.Y. Yun, A. Green, J. Li, R.L. Simmons, and T.R. Billiar Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling J. Neurosci. 19 1999 6740 6747
19. S.A. Lipton, Y.B. Choi, Z.H. Pan, S.Z. Lei, H.S. Chen, N.J. Sucher, J. Loscalzo, D.J. Singel, and J.S. Stamler A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds Nature 364 1993 626 632
20. S.J. McKinnon, D.M. Lehman, L.A. Kerrigan-Baumrind, C.A. Merges, M.E. Pease, D.F. Kerrigan, N.L. Ransom, N.G. Tahzib, H.A. Reitsamer, H. Levkovitch-Verbin, H.A. Quigley, and D.J. Zack Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension Invest. Ophthalmol. Vis. Sci. 43 2002 1077 1087
21. K. Mizuno, T. Koide, M. Yoshimura, and M. Araie Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action Invest. Ophthalmol. Vis. Sci. 42 2001 688 694
22. T. Nakazawa, H. Tomita, K. Yamaguchi, Y. Sato, M. Shimura, S. Kuwahara, and M. Tamai Neuroprotective effect of nipradilol on axotomized rat retinal ganglion cells Curr. Eye Res. 24 2002 114 122
23. A.H. Neufeld, M.R. hrernandez, and M. Gonzalez Nitric oxide synthase in the human glaucomatous optic nerve head Arch. Ophthalmol. 115 1997 497 503
24. A.H. Neufeld, A. Sawada, and B. Becker Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma Proc. Natl Acad. Sci. USA. 96 1999 9944 9948
25. A.H. Neufeld, S. Kawai, S. Das, S. Vora, E. Gachie, J.R. Connor, and P.T. Manning Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase Exp. Eye Res. 75 2002 521 528
26. R.W. Nickells Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death Surviv. Ophthalmol. 43 1999 S151 S161
27. A. Ohira, Y. Wada, M. Fujii, M. Nakamura, Y. Kasuya, Y. hramada, and K. Shigenobu Effects of nipradilol (K-351) on alpha-adrenoceptor mediated responses in various isolated tissues Arch. Int. Pharmacodyn. Ther. 278 1985 61 71
28. N.N. Osborne, N.L. Barnett, and A.J. hrerrera NADPH diaphorase localization and nitric oxide synthetase activity in the retina and anterior uvea of the rabbit eye Brain Res. 610 1993 194 198
29. V. Poulaki, C.S. Mitsiades, A.M. Joussen, A. Lappas, B. Kirchhof, and N. Mitsiades Constitutive nuclear factor-kB activity is crucial for human retinoblastoma cell viability Am. J. Pathol. 161 2002 2229 2240
30. H.A. Quigley, R.W. Nickells, L.A. Kerrigan, M.E. Pease, D.J. Thibault, and D.J. Zack Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis Invest. Ophthalmol. Vis. Sci. 36 1995 774 786
31. E. Schreiber, P. Matthias, M.M. Muller, and W. Schaffner Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells Nucleic. Acids Res. 17 1989 6419
32. E.A. Slee, M.T. hrarte, R.M. Kluck, B.B. Wolf, C.A. Casiano, D.D. Newmeyer, H.G. Wang, J.C. Reed, D.W. Nicholson, E.S. Alnemri, D.R. Green, and S.J. Martin Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2-3-6-7-8, and -10 in a caspase-9-dependent manner J. Cell Biol. 144 1999 281 292
33. M. Tamatani, N. Mitsuda, H. Matsuzaki, H. Okado, S. Miyake, M.P. Vitek, A. Yamaguchi, and M. Tohyama A pathway of neuronal apoptosis induced by hypoxia/reoxygenation: roles of nuclear factor-(B and Bcl-2 J. Neurochem. 75 2000 683 693
34. T. Thippeswamy, J.S. McKay, and R. Morris Bax and caspases are inhibited by endogenous nitric oxide in dorsal root ganglion neurons in vitro Eur. J. Neurosci. 14 2001 1229 1236
35. H. Tomita, T. Nakazawa, E. Sugano, T. Abe, and M. Tamai Nipradilol inhibits apoptosis by preventing the activation of caspase-3 via S-nitrosylation and the cGMP-dependent pathway Eur. J. Pharmacol. 452 2002 263 268
36. Y. Uchida, M. Nakamura, S. Shimizu, Y. Shirasawa, and M. Fujii Vasoactive and β-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3- isopropylamino)propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent Arch. Int. Pharmacodyn. Ther. 262 1983 132 149
37. A.M. Verhagen, P.G. Ekert, M. Pakusch, J. Silke, L.M. Connolly, G.E. Reid, R.L. Moritz, R.J. Simpson, and D.L. Vaux Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins Cell 102 2000 43 53
38. C.K. Vorwerk, B.T. hryman, J.W. Miller, D. hrusain, D. Zurakowski, P.L. hruang, M.C. Fishman, and E.B. Dreyer The role of neuronal and endothelial nitric oxide synthase in retinal excitotoxicity Invest. Ophthalmol. Vis. Sci. 38 1997 2038 2044
39. C.Y. Wang, M.W. Mayo, and A.S. Baldwin Jr TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB Science 274 1996 784 787